Sevelamer Hydrochloride Tablet, Film Coated
Product Images NDC 60687-449

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 60687-449). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp44901

Sevelamer Hydrochloride 800 mg film-coated oral tablet with imprint G447 on one side and plain on the other. The white, oblong tablet is manufactured by American Health Packaging.*

FDA Label Image

Blister

Sevelamer Hydrochloride 800 mg film-coated tablet labels arranged in a sheet format. Each label includes the product name, strength (800 mg), dosage form (tablet), bar code, expiration date, lot number, and American Health Packaging as the labeler in Columbus, Ohio. NDC number 60687-449 is printed on each label.*

FDA Label Image

Carton

Sevelamer Hydrochloride 800 mg film-coated tablets label from American Health Packaging. The package contains 100 tablets (10 blister packs of 10). The label includes the product name, strength, quantity, barcode, and storage instructions. It also notes that it is prescription-only and provides distributor information.*

FDA Label Image

Figure 2

A line graph showing the percentage of patients with at least a specified reduction in serum phosphorus (mg/dL) on the x-axis versus the percentage of patients achieving that reduction or more on the y-axis. Two lines compare Sevelamer Hydrochloride and an active control, illustrating patient response in serum phosphorus reduction from baseline.*

FDA Label Image

Figure 3

A line graph showing phosphorus change from baseline over 52 weeks of study. The x-axis represents study weeks from 0 to 52, and the y-axis shows phosphorus change ranging from -5 to 2. Two treatment groups are plotted: Sevelamer Hydrochloride (black circles) and Active-Control (red squares), both showing an initial reduction in phosphorus levels that stabilize over time.*

FDA Label Image

Structure

Chemical structure diagram of Sevelamer Hydrochloride polymer, showing repeating units with amino and hydroxyl groups and associated hydrochloride (HCl) components in a complex polymeric form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.